文献速递前列腺癌

泌尿外科医生、肿瘤内科医生和执业护士对转移性前列腺癌主流化基因检测的体验

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-12-05

荷兰15家医院的前瞻性队列研究,167名非遗传学医疗专业人员(ngHCPs)受邀,69名完成首份及末份问卷。完成45分钟在线培训并实践9个月后,认为主流化路径有帮助者从81%升至94%(p=0.01),感知与实际遗传学知识均显著提高,82%的ngHCPs pre-test遗传咨询用时少于10分钟,88%赞成继续主流化路径。

要点

  • 完成45分钟在线培训后,ngHCPs对自身提供pre-test遗传咨询准备充分。
  • 9个月后认为主流化有帮助者94% vs 培训前81%(p=0.01)。
  • 82%的ngHCPs pre-test遗传咨询用时少于10分钟,88%赞成继续主流化路径。

核心结论

  • 完成短期在线培训模块后,ngHCPs感到准备充分,能够与转移性前列腺癌患者讨论胚系基因检测。

研究设计与样本

  • 前瞻性队列研究,在荷兰15家医院开展。
  • 所有参与ngHCPs(泌尿外科医生、肿瘤内科医生、专科护士和执业护士)完成45分钟在线培训模块。
  • 167名ngHCPs受邀,69名完成首份问卷并开始或完成末份问卷。
  • ngHCPs在培训前及培训后3个月和9个月完成问卷,采用配对分析比较首份与末份问卷。

主要发现

  • ngHCPs对自身提供基因检测持积极态度。
  • 提供pre-test遗传咨询9个月后,认为主流化有帮助者94% vs 培训前81%(p=0.01)。
  • 感知知识和实际知识均显著提高。
  • 82%的ngHCPs pre-test遗传咨询用时少于10分钟。
  • 多数(88%)赞成继续主流化路径;仅6名参与ngHCPs认为事先未完成培训模块也可能开展主流化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: International guidelines recommend germline genetic testing for men with metastatic prostate cancer. If offered to all patients by genetic healthcare professionals, there will be insufficient capacity to cope with the high patient numbers. In a mainstreaming pathway, non-genetic healthcare professionals (ngHCPs) discuss and order germline genetic testing instead of referring patients to genetic healthcare professionals. We aimed to evaluate the experience of ngHCPs with pre-test genetic counselling and to explore the feasibility from the ngHCPs' perspective. METHODS: We carried out a prospective cohort study in 15 hospitals in the Netherlands. All participating ngHCPs (i.e. urologists, medical oncologists, specialist nurses and nurse practitioners) completed an online training module of 45 min. The ngHCPs completed a questionnaire both before the training and at three and nine months after it. Paired analyses were used to compare the first with the last questionnaires on attitude, confidence in the ability to discuss and order germline genetic testing, and perceived and actual knowledge of genetics and genetic testing. RESULTS: 167 ngHCPs were invited to participate of whom 69 completed the first questionnaire and started or completed the last one. They had a positive attitude towards offering genetic testing themselves. After nine months of providing pre-test genetic counselling, significantly more ngHCPs considered mainstreaming helpful (94% after versus 81% before, p = 0.01). Both perceived and actual knowledge increased significantly. Pre-test genetic counselling took less than 10 minutes for 82% of ngHCPs and the majority (88%) were in favour of continuing the mainstream pathway. Only six participating ngHCPs considered mainstreaming possible without completing a training module beforehand. CONCLUSIONS: After completing a short online training module, ngHCPs feel well-prepared to discuss germline genetic testing with metastatic prostate cancer patients.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Vlaming M, Ausems MGEM, Kiemeney LALM, et al. Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2024. PMID: 39639158. doi:10.1038/s41391-024-00925-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。